Active ingredientTrabectedinCat. No. P-T171-001CAS 114899-77-3Family · Pharmaceutical analytical standards
Trabectedin
A marine-derived anticancer drug obtained from the Caribbean sea squirt Ecteinascidia turbinata, whose extract showed anticancer activity in 1969; approved in Europe in 2007 for advanced soft tissue sarcoma. This family brings together the active ingredient and other impurities.
Did you know?Isolating a single gram took about a thousand kilograms of sea squirts: today it is made by semi-synthesis from safracin B, obtained by fermenting the bacterium Pseudomonas fluorescens.
Go to the active ingredient →Active ingredientTrabectedinCat. No. P-T171-001CAS 114899-77-3
ImpurityCyanosafracin BCat. No. P-T171-002CAS 96996-50-8
ImpurityEcteinascidin 770Cat. No. P-T171-003CAS 114899-80-8
ImpurityEcteinascidine 729Cat. No. P-T171-004CAS 114899-27-3
ImpurityTrabectedin Desacetyl ImpurityCat. No. P-T171-005CAS 493024-42-3
ImpurityTrabectedin Deshydroxy ImpurityCat. No. P-T171-006CAS 114899-28-4
ImpurityTrabectedin Impurity 1Cat. No. P-T171-007CAS 1376626-08-2
ImpurityTrabectedin Impurity 2Cat. No. P-T171-008
ImpurityTrabectedin Impurity 3Cat. No. P-T171-009
ImpurityTrabectedin Impurity 4Cat. No. P-T171-011
ImpurityTrabectedin Impurity 5Cat. No. P-T171-013CAS 182201-61-2
ImpurityTrabectedin Sulfoxide ImpurityCat. No. P-T171-015CAS 631920-73-5No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.